Title

Aging, gender and APOE isotype modulate metabolism of Alzheimer's ABeta peptides and F2-isoprostanes in the absence of detectable amyloid deposits

Document Type

Journal Article

Publisher

Blackwell

Place of Publication

United Kingdom

School

School of Exercise, Biomedical and Health Science

RAS ID

2878

Comments

Originally published as: Yao, J., Petanceska, S., Montine, T., Holtzman, D., Schmidt,S., Parker,C.,...Gandy,S. (2004). Aging, gender and APOE isotype modulate metabolism of Alzheimer's ABeta peptides and F2-isoprostanes in the absence of detectable amyloid deposits. The journal of Neurochemistry. 90(4), 1011 - 1018. Original paper is available here

Abstract

Aging and apolipoprotein E (APOE) isoform are among the most consistent risks for the development of Alzheimer's disease (AD). Metabolic factors that modulate risk have been elusive, though oxidative reactions and their by-products have been implicated in human AD and in transgenic mice with overt histological amyloidosis. We investigated the relationship between the levels of endogenous murine amyloid β (Aβ) peptides and the levels of a marker of oxidation in mice that never develop histological amyloidosis [i.e. APOE knockout (KO) mice with or without transgenic human APOEɛ3 or human APOEɛ4 alleles]. Aging-, gender-, and APOE-genotype-dependent changes were observed for endogenous mouse brain Aβ40 and Aβ42 peptides. Levels of the oxidized lipid F2-isoprostane (F2-isoPs) in the brains of the same animals as those used for the Aβ analyses revealed aging- and gender-dependent changes in APOE KO and in human APOEɛ4 transgenic KO mice. Human APOEɛ3 transgenic KO mice did not exhibit aging- or gender-dependent increases in F2-isoPs. In general, the changes in the levels of brain F2-isoPs in mice according to age, gender, and APOE genotype mirrored the changes in brain Aβ levels, which, in turn, paralleled known trends in the risk for human AD. These data indicate that there exists an aging-dependent, APOE-genotype-sensitive rise in murine brain Aβ levels despite the apparent inability of the peptide to form histologically detectable amyloid. Human APOEɛ3, but not human APOEɛ4, can apparently prevent the aging-dependent rise in murine brain Aβ levels, consistent with the relative risk for AD associated with these genotypes. The fidelity of the brain Aβ/F2-isoP relationship across multiple relevant variables supports the hypothesis that oxidized lipids play a role in AD pathogenesis, as has been suggested by recent evidence that F2-isoPs can stimulate Aβ generation and aggregation.

DOI

10.1111/j.1471-4159.2004.02532.x

 

Link to publisher version (DOI)

10.1111/j.1471-4159.2004.02532.x